首页 | 本学科首页   官方微博 | 高级检索  
     


A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705
Authors:Hiroshige Yoshioka  Katsuyuki Hotta  Katsuyuki Kiura  Nagio Takigawa  Hidetoshi Hayashi  Shingo Harita  Shoichi Kuyama  Yoshihiko Segawa  Haruhito Kamei  Shigeki Umemura  Akihiro Bessho  Masahiro Tabata  Mitsune Tanimoto
Affiliation:2. Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan;3. Department of Medicine, Chugoku Central Hospital, Fukuyama, Japan;4. Department of Respiratory Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan;5. Department of Respiratory Medicine, NHO Iwakuni Medical Center, Iwakuni, Japan
Abstract:
Keywords:Non-small cell lung cancer  Erlotinib
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号